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OBJECTIVE — The epidemiological association between coffee drinking and decreased risk
oftype2diabetesisstrong.However,caffeinatedcoffeeacutelyimpairsglucosemetabolism.We
assessed acute effects of decaffeinated coffee on glucose and insulin levels.
RESEARCHDESIGNANDMETHODS — Thiswasarandomized,cross-over,placebo-
controlled trial of the effects of decaffeinated coffee, caffeinated coffee, and caffeine on glucose,
insulin,andglucose-dependentinsulinotropicpolypeptide(GIP)levelsduringa2-horalglucose
tolerance test (OGTT) in 11 young men.
RESULTS — Within the ﬁrst hour of the OGTT, glucose and insulin were higher for decaf-
feinatedcoffeethanforplacebo(P0.05).DuringthewholeOGTT,decaffeinatedcoffeeyielded
higher insulin than placebo and lower glucose and a higher insulin sensitivity index than
caffeine. Changes in GIP could not explain any beverage effects on glucose and insulin.
CONCLUSIONS — Some types of decaffeinated coffee may acutely impair glucose metab-
olism but less than caffeine.
Diabetes Care 33:278–280, 2010
N
ineteen of 22 epidemiological
studies concluded that long-term
consumption of coffee, both caf-
feinatedanddecaffeinated,canreducethe
risk of type 2 diabetes (1–3), but several
investigators have warned that the caf-
feine in caffeinated coffee can impair glu-
cose metabolism (e.g., 4,5). While
decaffeinated coffee contains very little
caffeine and may safely protect against di-
abetes, there have been conﬂicting re-
ports on decaffeinated coffee’s acute
effects on glucose metabolism (6–9). Our
objective was to assess whether ground
decaffeinated coffee enhances glucose
metabolism and whether glucose-
dependent insulinotropic polypeptide
(GIP), an incretin hormone that stimu-
lates insulin secretion (10), plays a causal
role.
RESEARCH DESIGN AND
METHODS— Eleven healthy male
nonsmokers signed an informed consent
andparticipated.Thefollowingparticipa-
tion requirements were started 1 week
prior to the ﬁrst lab visit: keep diet, exer-
cise, and alcohol intake stable; no caffein-
ated drinks, foods, or medications; no
smoking; and no alcohol or exercise dur-
ing the 48 h prior to each visit.
There were four visits separated by at
least a week. Participants ingested one of
four beverages assigned by researchers in
a single-blinded randomized fashion at a
temperature of 43–49°C (caffeinated cof-
fee, decaffeinated coffee, caffeine in warm
water, or warm water [placebo]). An oral
glucose tolerance test (OGTT) was initi-
ated1hlater(t0min)withingestionof
75gofglucoseinwater.Bloodwasdrawn
at time 90, 60, 0, 10, 30, 60, 90, and
120 min.
Participants drank 500–600 ml of
drip-ﬁltered ground coffee (Chock Full
O’Nuts Original; Massimo Zanetti Bever-
age, Portsmouth, VA). The recipe was
eight cups of water with 40 g of grounds
for caffeinated and 57 g of grounds for
decaffeinated coffee. For the caffeine and
hot water (placebo) beverages, we ran
eight cups of water through the machine
with ﬁlter paper without coffee grounds.
Forthecaffeinebeverage,weaddedfood-
grade caffeine powder (Spectrum Chem-
ical Manufacturing, Gardena, CA). The
volume ingested was the same for each
beverage and differed by participant to
yield 6 mg caffeine/kg of body wt in the
caffeine and caffeinated coffee beverage.
The caffeine content of the caffeinated
coffee was measured as 0.73 mg/ml
coffee, by high-performance liquid chro-
matography.
Glucose was assayed in plasma using
the oxygen rate method (Beckman Glucose
Analyzer 2; Beckman, Brea, CA). Insulin
was assayed in plasma (human-speciﬁc ra-
dioimmunoassay kit no. M114886; Milli-
pore, Billerica, MA). GIP (total) was
measuredinplasma(humanGIP[total]en-
zyme-linked immunosorbent assay kit no.
M116520; Millipore).
The trapezoidal rule was used to cal-
culate area under the curve (AUC). The
insulin sensitivity index (ISI) was calcu-
lated using the formula of Belﬁore et al.
(11). All blood data were analyzed for
time and beverage effects using two-way
repeated-measures ANOVA. AUC and
ISI data were analyzed using one-way
repeated-measures ANOVA. All tests
were adjusted for multiple comparisons
by means of Tukey Studentized range ad-
justments. Two-sided P  0.05 was con-
sideredsigniﬁcant.WeusedSPSS11.5for
all statistical analyses.
RESULTS— The subjects had a mean
( SD) age of 23.5  5.7 years, BMI
23.6  4.2 kg/m
2, fasting glucose 4.41 
0.49 pmol/l, and fasting insulin 109.0 
91.7 pmol/l. Participants reported no
nonminor adverse reactions.
During the ﬁrst 30 min of the OGTT,
decaffeinated coffee yielded signiﬁcantly
higher glucose than placebo (Table 1).
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signiﬁcantlylowerthanforcaffeine.Insu-
lin was signiﬁcantly higher after caffeine
and decaffeinated coffee than after pla-
cebo during the ﬁrst hour of the OGTT.
Insulin AUC was signiﬁcantly higher for
caffeine and decaffeinated coffee than for
placebo.
ISI(meansSE)was1.220.07for
placebo, 0.98  0.09 for caffeine, 1.09 
0.08 for decaffeinated coffee, and 0.97 
0.09 for caffeinated coffee. ISI for decaf-
feinated coffee was signiﬁcantly higher
than for caffeine and showed a trend to-
ward being lower than for placebo (P 
0.052). Caffeinated coffee induced effects
onglucoseandinsulinthatweresimilarto
those for caffeine. GIP decreased after in-
gestion of all beverages and became sig-
niﬁcantly lower for decaffeinated coffee
than for caffeine and placebo 60 min after
beverage ingestion.
CONCLUSIONS — Decaffeinated cof-
fee acutely impaired glucose metabolism
in healthy young men. Within the ﬁrst 60
min of the OGTT, both glucose and insu-
lin were signiﬁcantly higher after decaf-
feinated coffee than after placebo. During
thewholeOGTT,insulinAUCwassignif-
icantly higher for decaffeinated coffee
thanplacebo.Decaffeinatedcoffeedidnot
impair glucose metabolism as severely as
caffeine. During the whole OGTT, decaf-
feinated coffee yielded lower glucose
AUC and higher ISI than caffeine. Our
ﬁndings require conﬁrmation in future
studies. However, they do suggest that
caution is needed in the quest to harness
coffee’s potential to reduce the risk of di-
abetes, demonstrated in epidemiological
studies.
Battram et al. (6) found an acute
enhancement of glucose metabolism
by ground decaffeinated coffee, and
Johnston et al. (7), Thom (8), and van
Dijk et al. (9) found no acute effect on
glucose metabolism by instant decaffein-
ated coffee. It is possible that our
decaffeinated coffee had a higher con-
centration of caffeine (12) than the
decaffeinated coffees of these investiga-
tors, or that our decaffeinated coffee
had lower concentrations of noncaf-
feinecompounds,whichacutelyenhance
glucose metabolism. It seems unlikely
that GIP played a role in our observed
beverage effects. For example, 60 min af-
ter beverage ingestion, decaffeinated cof-
fee yielded signiﬁcantly lower GIP than
placebo and caffeine but no signiﬁcant
changes in insulin or glucose.
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Greenberg, Owen, and Geliebter
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 2, FEBRUARY 2010 279Our study has several limitations.
We only had 11 volunteers. More vol-
unteers would have yielded more statis-
tical power. Our study also has some
strengths. Our protocol allowed us to
convincingly separate the effects of each
beverage from the effects of the OGTT
glucose because ingestion of the bever-
ages was separated by 60 min from inges-
tion of the glucose.
In conclusion, our human trial ap-
pears to be the ﬁrst to ﬁnd that decaffein-
ated coffee can acutely impair glucose
metabolism, but less than caffeine, in
healthy young men.
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